Boston Scientific Corp (BSX) stock

BSXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3051% below fair value

$44.20−0.93 (-2.06%)

Close on Nov 12, 2026Market cap $64.06BP/E 18.7Yield –

Boston Scientific profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Boston Scientific has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Boston Scientific's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Nov 6, 2003
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing